Novartis UK are a leading pharmaceutical company who provide treatment of Spinal Muscular Atrophy. They have been instrumental in providing support to the iHV to develop resources and training to empower health visitors in their role of early identification and access to treatment for SMA.  They have supported the iHV to develop a range of resources in including: 

• Motor development toolkit available to all iHV members
• Good practice points - Spinal Muscular Atrophy
• Development of Motor Development Ambassador training